NCT00191516View on ClinicalTrials.gov

An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder

PHASE3CompletedINTERVENTIONAL

Enrollment

257

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

February 28, 2006

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG

Atomoxetine

Trial Locations (1)

D-50931

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Cologne

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00191516 - An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder | Biotech Hunter | Biotech Hunter